CV Sciences, Inc. vs Johnson & Johnson
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $20 M for CV Sciences, Inc., 32624 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 29, 2026 for Johnson & Johnson). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
- Johnson & Johnson had more revenue: $94.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025.
- Johnson & Johnson made a net profit of $26.8 B, while CV Sciences, Inc. made a net loss of $1 M.
- Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -7.0% for CV Sciences, Inc.
- Johnson & Johnson employs more people: 138,200 against 44 at CV Sciences, Inc. Each employee brings in about $313,409 of revenue at CV Sciences, Inc. and $681,570 at Johnson & Johnson.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | CV Sciences, Inc. CVSI | Johnson & Johnson JNJ · #23 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2010 | 1886 |
| Size | ||
| Market cap | $20 M* | $652.5 B |
| Revenue | $14 M | $94.2 B |
| Net income | $-1 M | $26.8 B▲ best |
| Employees | 44 | 138,200 |
| Valuation | ||
| P/E ratio | — | 40.5× |
| Price to sales | — | 6.6× |
| Price to book | — | 8.0× |
| Free cash flow yield | — | 3.0% |
| Profitability | ||
| Gross margin | 49.0% | — |
| Operating margin | -3.4% | — |
| Net margin | -7.0% | — |
| Return on equity | -58.7% | — |
| Growth | ||
| Revenue growth | -12.2% | — |
| Revenue growth, 3 years a year | -5.2% | — |
| Financial strength | ||
| Debt to equity | 1.1× | — |
| Cash | ||
| Free cash flow margin | -3.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2022; ratios FY2025 | Market cap Oct 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, CV Sciences, Inc. or Johnson & Johnson?
Johnson & Johnson is the larger company by market value: $652.5 B against $20 M for CV Sciences, Inc., 32624 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 29, 2026 for Johnson & Johnson). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, CV Sciences, Inc. or Johnson & Johnson?
Johnson & Johnson had more revenue: $94.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025. Johnson & Johnson made a net profit of $26.8 B, while CV Sciences, Inc. made a net loss of $1 M.
Which is more profitable, CV Sciences, Inc. or Johnson & Johnson?
Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -7.0% for CV Sciences, Inc.
Which has more employees, CV Sciences, Inc. or Johnson & Johnson?
Johnson & Johnson employs more people: 138,200 against 44 at CV Sciences, Inc. Each employee brings in about $313,409 of revenue at CV Sciences, Inc. and $681,570 at Johnson & Johnson.
More about CV Sciences, Inc.
More about Johnson & Johnson
Sources#
Every figure on this page comes from these, with the date shown next to it.